Position in DXCM
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,250,364
-$306,349 QoQ
Shares Held
33,413
-17.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#372
of 966 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Avanza Fonder AB holds $57,374,354 across 10 Medical Devices names. DXCM ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
188,859 | $17,137,065 | |
| 2 | SYK |
Stryker Corp
|
42,219 | $13,292,229 | |
| 3 | MDT |
Medtronic plc
|
126,616 | $9,905,168 | |
| 4 | BSX |
Boston Scientific Corp
|
179,197 | $7,648,127 | |
| 5 | EW |
Edwards Lifesciences Corp
|
66,294 | $5,996,954 | |
| 6 | DXCM |
Dexcom Inc
This page
|
33,413 | $2,250,364 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
14,484 | $927,120 | |
| 8 | NEOG |
Neogen Corp
|
9,675 | $86,978 |
All Filings in DXCM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,250,364 | 33,413 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $2,556,713 | 40,712 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $2,883,244 | 43,442 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $2,985,790 | 44,372 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $3,870,087 | 44,336 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $3,097,291 | 45,355 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $3,731,170 | 47,977 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||